Invited Commentary to:‘Clinical Pathways as a Tool for Process Costing in Cardiac Surgery’ (Eur. Surg. 2003;35:51–54)

IF 0.6 4区 医学 Q4 SURGERY
W. Mohl
{"title":"Invited Commentary to:‘Clinical Pathways as a Tool for Process Costing in Cardiac Surgery’ (Eur. Surg. 2003;35:51–54)","authors":"W. Mohl","doi":"10.1046/j.1682-4016.2003.03030.x","DOIUrl":null,"url":null,"abstract":"<p><b>Summary:</b><b> Background:</b> By developing a standard clinical pathway, we tried to assess the cost of a coronary bypass procedure at our in institution in order to find possibilities for cost containment and financial decision-making.</p><p><b>Methods:</b> A standard clinical pathway was designed for an aortocoronary bypass procedure. Using this pathway, we assessed the procedural costs in a stepwise manner for each individual patient to obtain the average cost for a bypass operation at our institution.</p><p><b>Results:</b> Overall costs for a standard coronary bypass operation at our institution were 7,411 EUR. Costs for the surgical procedure, intensive care unit, intermediate care unit and 9 days on the ward were 3,722 EUR, 1,171 EUR, 271 EUR and 558 EUR, respectively. Expenses for personnel amounted to 3,194 EUR; for drugs, 78 EUR; for disposables, 2,919 EUR; for diagnostics, 274 EUR; and indirect costs, 609 EUR.</p><p><b>Conclusions:</b> Standard clinical pathways are a valid means for assessing procedural costs. Making costs transparent is the basis for cost containment, benchmarking and financial decision-making in cardiac surgery.</p>","PeriodicalId":50475,"journal":{"name":"European Surgery-Acta Chirurgica Austriaca","volume":null,"pages":null},"PeriodicalIF":0.6000,"publicationDate":"2009-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1046/j.1682-4016.2003.03030.x","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Surgery-Acta Chirurgica Austriaca","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1046/j.1682-4016.2003.03030.x","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Summary: Background: By developing a standard clinical pathway, we tried to assess the cost of a coronary bypass procedure at our in institution in order to find possibilities for cost containment and financial decision-making.

Methods: A standard clinical pathway was designed for an aortocoronary bypass procedure. Using this pathway, we assessed the procedural costs in a stepwise manner for each individual patient to obtain the average cost for a bypass operation at our institution.

Results: Overall costs for a standard coronary bypass operation at our institution were 7,411 EUR. Costs for the surgical procedure, intensive care unit, intermediate care unit and 9 days on the ward were 3,722 EUR, 1,171 EUR, 271 EUR and 558 EUR, respectively. Expenses for personnel amounted to 3,194 EUR; for drugs, 78 EUR; for disposables, 2,919 EUR; for diagnostics, 274 EUR; and indirect costs, 609 EUR.

Conclusions: Standard clinical pathways are a valid means for assessing procedural costs. Making costs transparent is the basis for cost containment, benchmarking and financial decision-making in cardiac surgery.

受邀评论:“临床路径作为心脏外科过程成本计算的工具”(Eur.Surg.2003;35:51-54)
摘要:背景:通过制定标准临床路径,我们试图评估我们机构内冠状动脉搭桥手术的成本,以寻找控制成本和做出财务决策的可能性。方法:为主动脉-冠状动脉搭桥术设计标准临床路径。利用这一途径,我们逐步评估了每位患者的手术成本,以获得我们机构搭桥手术的平均成本。结果:我们机构标准冠状动脉搭桥手术的总费用为7411欧元。外科手术、重症监护室、中间监护室和9天病房的费用分别为3722欧元、1171欧元、271欧元和558欧元。人事费共计3194欧元;药品,78欧元;一次性用品,2919欧元;用于诊断,274欧元;以及间接成本,609欧元。结论:标准临床路径是评估手术成本的有效手段。使成本透明是心脏手术成本控制、基准测试和财务决策的基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.10
自引率
0.00%
发文量
36
审稿时长
6-12 weeks
期刊介绍: The journal European Surgery – Acta Chirurgica Austriaca focuses on general surgery, endocrine surgery, thoracic surgery, heart and vascular surgery. Special features include new surgical and endoscopic techniques such as minimally invasive surgery, robot surgery, and advances in surgery-related biotechnology and surgical oncology. The journal especially addresses benign and malignant esophageal diseases, i.e. achalasia, gastroesophageal reflux disease, Barrett’s esophagus, and esophageal adenocarcinoma. In keeping with modern healthcare requirements, the journal’s scope includes inter- and multidisciplinary disease management (diagnosis, therapy and surveillance).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信